Bimeda, Inc. is recalling 606 bottles of Dexium 0.25 mg (dexamethasone) tablets because the product failed to meet USP dissolution requirements during stability testing. Dexium is a veterinary steroid medication used to treat various conditions in animals, and this recall affects bottles containing 1000 tablets each. Because the tablets may not dissolve properly, the medication may not be absorbed effectively by the animal, leading to potential treatment failure. Consumers should contact their veterinarian or pharmacist immediately to discuss alternative treatments.
The tablets failed stability testing because they did not dissolve at the required rate, which means the active medication (dexamethasone) may not be released into the animal's system as intended. This can result in the animal receiving an inadequate dose, preventing the effective treatment of the underlying medical condition.
Veterinary drug refund and professional consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response